Selected article for: "disease progression and potential target"
Author: Liu, Mingli; Guo, Shanchun; Hibbert, Jacqueline M.; Jain, Vidhan; Singh, Neeru; Wilson, Nana O.; Stiles, Jonathan K.
Title: CXCL10/IP-10 in Infectious Diseases Pathogenesis and Potential Therapeutic Implications
  • Cord-id: azj7d8qu
  • Document date: 2011_7_1
    • ID: azj7d8qu
    Snippet: C-X-C motif chemokine 10 (CXCL10) also known as interferon γ-induced protein 10 kDa (IP-10) or small-inducible cytokine B10 is a cytokine belonging to the CXC chemokine family. CXCL10 binds CXCR3 receptor to induce chemotaxis, apoptosis, cell growth and angiostasis. Alterations in CXCL10 expression levels have been associated with inflammatory diseases including infectious diseases, immune dysfunction and tumor development. CXCL10 is also recognized as a biomarker that predicts severity of vari
    Document: C-X-C motif chemokine 10 (CXCL10) also known as interferon γ-induced protein 10 kDa (IP-10) or small-inducible cytokine B10 is a cytokine belonging to the CXC chemokine family. CXCL10 binds CXCR3 receptor to induce chemotaxis, apoptosis, cell growth and angiostasis. Alterations in CXCL10 expression levels have been associated with inflammatory diseases including infectious diseases, immune dysfunction and tumor development. CXCL10 is also recognized as a biomarker that predicts severity of various diseases. A review of the emerging role of CXCL10 in pathogenesis of infectious diseases revealed diverse roles of CXCL10 in disease initiation and progression. The potential utilization of CXCL10 as a therapeutic target for infectious diseases is discussed.

    Search related documents:
    Co phrase search for related documents
    • abnormal level and acute disease: 1, 2, 3, 4
    • abnormal level and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • abnormal level and liver damage: 1
    • abnormal level and lung adenocarcinoma: 1
    • abnormal level and lung cancer: 1
    • abnormal level and lung injury: 1
    • absence presence and acute disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • absence presence and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
    • absence presence and adaptive immune response: 1, 2
    • absence presence and adaptive immune response innate: 1
    • absence presence and adaptive innate: 1, 2
    • absence presence and adoptive transfer: 1, 2
    • absence presence and liver damage: 1, 2
    • absence presence and liver enzyme: 1, 2, 3
    • absence presence and lung adenocarcinoma: 1, 2, 3
    • absence presence and lung cancer: 1, 2, 3, 4
    • absence presence and lung injury: 1, 2, 3, 4
    • absence presence and lymphocyte macrophage: 1
    • absence presence and lymphoma cell: 1, 2